pt141 spray PT-141 Bremelanotide Nasal PT-141 Nasal Spray (Bremelanotide) -

GPX4 catalyzes the substrate, and the product consumes the reducing agent with the addition of enzyme reagents.The reducing agent has a maximum absorbance at 340 nm, and the GP4-specific enzyme activity can be calculated by measuring non-specific enzyme activity and total enzyme activity by adding GPX-4 inhibitor to the system

Ingredients 3% Glutathione, 10% Vitamin C, 5% Lactic acid, 5% Niacinamide, 2% Alpha Arbutin, 1% Hyaluronic acid

Moreover, it has been observed that NLRP12 overexpression activates caspase-1 and NF-, which causes macrophages to secrete IL-1

J.SandersonS

Balza E, Castellani P, Delfino L, Truini M, Rubartelli A